Abstract
In the manufacturing process for Biaxin® (clarithromycin), erythromycin-A oxime, an intermediate, is obtained in high yield, when erythromycin-A is treated with hydroxylamine/isopropyl alcohol in the presence of acetic acid. An unusual impurity, the desosamine hydrazinium salt, is generated in this step of the synthetic pathway, and has been isolated and characterized by using one and two-dimensional NMR spectroscopy in conjunction with MS and EDS.
Article PDF
References
Mcguire JM, Bunch RL, Anderson RC, Boaz HE, Flynn EH, Powell HM, Smith JW . “Ilotycin,” a new antibiotic. Antibiot Chemother 2: 281–283 ( 1952)
Washington JA, Wilson WR . Erythromycin: A microbial and clinical perspective after 30 years of clinical use. Mayo Clin Proc 60: 189–203, 271–278 ( 1985)
Kurath P, Jones RS, Egan RS, Perun TJ . Acid degradation of erythromycin A and erythromycin B. Experientia 27: 362 ( 1971)
Atkins PJ, Herbert TO, Jones NB . Kinetic studies on the decomposition of erythromycin A in aqueous acidic and neutral buffers. Int J Pharm 30: 199–207 ( 1986)
Gasc JC, Gouin D'ambrieres S, Lutz A, Chantot JF . New ether oxime of erythromycin A a structure activity relationship study. J Antibiot 44: 313–330 ( 1991)
Chantot JF, Bryskier A, Gasc JC . Antibacterial activity of roxithromycin: a laboratory evaluation. J Antibiot 39: 660–668 ( 1986)
Morimoto S, Takahashi Y, Watanabe Y, Omura S . Chemical modifications of erythromycins I. Synthesis and antibacterial activity of 6-O-methylerythromycin A. J Antibiot 37: 187–189 ( 1984)
Retsema JA, Girard AE, Schekly W, Manousos M, Anderson MR, Bright GM, Borovoy RJ, Brennan LA, Mason R . Spectrum and mode of action of azithromycin (CP-62,993), a new 15 membered-ring macrolide with improved potency against gram negative organisms. Antimicrob Agents Chemother 31: 1939–1947 ( 1987)
Chu D . Recent developments in 14- and 15-membered macrolides. Exp Opin Invest Drugs 4: 65–94 ( 1995)
Chang Sou-Jen . Process for preparing erythromycin A oxime. WO 97/38000, PCT/US97/03177 ( 1997)
Massey EH, Kitchell B, Martin LD, Gerzon K, Murphy HW . Erythromycylamine. Tetrahedron Lett 2: 157–160 ( 1970)
Takehiro Amano U, Masami Goi S, Kazuto Sekiuchi T, Tomomichi Yoschida MH . Process for preparing erythromycin A oxime or a salt thereof. US 5 274 085 A ( 1993)
Egan RS, Freiberg LA, Washburn WH . Configuration of 9-imino derivatives of erythromycin. J Org Chem 39: 2492–2494 ( 1974)
McGill JM, Johnson R . Structural and conformational analysis of (E)-erythromycin A oxime. Magn Reson Chem 31: 273–277 ( 1993)
Omietanski GM, Sisler HH . The reaction of chloramines with tertiary amines. 1,1,1-Trisubstituted hydrazinium salts. J Am Chem Soc 78: 1211–1213 ( 1956)
Sisler HH, Bafford RA, Omietanski GM, Rudner B, Drago RJ . Amination of tertiary amines by hydroxylamine-O-sulfonic acid. J Org Chem 24: 859–861 ( 1959)
Tamura Y, Minamikawa J, Kita Y, Kim JH, Ikeda M . N-amination of tertiary amines: a novel method for 1,1,1-trisubstituted hydrazinium salts. Tetrahedron 29: 1063–1068 ( 1973)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zhou, C., Huang, X., Ford, K. et al. Isolation and Identification of a Novel Impurity of Erythromycin A 9-Oxime Desosaminehydrazinium Salt. J Antibiot 58, 539–544 (2005). https://doi.org/10.1038/ja.2005.75
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ja.2005.75